Senior Director, Product development, Quality, Costing, and Regulatory Affairs
Clinton Health Access Initiative (CHAI)
Melynda Watkins is the Senior Director of the Product development, Quality, Costing, and Regulatory Affairs Team at the Clinton Health Access Initiative (CHAI). She has been at CHAI since 2012. She is a highly experienced drug development and regulatory affairs professional, with over 20 years of experience in the pharmaceutical industry and global public health non-profit sector, with a passion for saving lives by developing quality-assured medical products for low- and middle-income countries. She has a proven record of successful development programs leading to product approvals via Stringent Regulatory Authorities such as the US FDA or through the WHO Prequalification Program. She has significant experience in partnering with private sector for sustainable solutions to expand access to lifesaving therapies.
Disclosure(s): No financial relationships to disclose
Wheel of (Mis)Fortune: Global Partnerships to Tackle Pediatric Infectious Diseases
Friday, March 29, 2024
8:15 AM – 9:15 AM MDT